Camlist vs Abridge
Side-by-side comparison of AI visibility scores, market position, and capabilities
Video-first pet marketplace connecting breeders with buyers for transparent puppy and kitten transactions; YC-backed with $1M revenue receiving M&A offer competing with PuppyFind.
About
Camlist is a video-first pet marketplace and social platform connecting pet breeders with prospective pet buyers in the US, UK, and UAE — enabling breeders to post video content of their animals (dogs, cats, and other pets), build a following, and sell pets through a marketplace that prioritizes video transparency over static photos to help buyers better assess puppies and kittens before purchase. Founded in 2020 and a Y Combinator W21 graduate, Camlist raised $1.43 million from Brickyard and Goodwater Capital, reaching $1 million in revenue in 2024 with a 5-person team and receiving an M&A acquisition offer in April 2025.\n\nCamlist's video-first approach addresses a significant problem in pet commerce — online pet scams (fraudulent breeders taking deposits for non-existent animals) have been a persistent consumer fraud issue, and static photos provide insufficient information about a puppy's personality, health, and conditions. Video content allows buyers to see puppies playing, interacting with people, and growing over time, creating more trust and better purchase decisions. The social layer (following favorite breeders, viewing litters over time) builds longer-term breeder-buyer relationships.\n\nIn 2025, Camlist competes in the pet marketplace market with PuppyFind, AKC Marketplace, and Petfinder for pet adoption and purchase platforms. The pet commerce market is large — Americans spend $150+ billion on pets annually, with pet acquisition representing a significant transaction. The M&A interest received in April 2025 reflects strategic value in Camlist's pet marketplace position and video-native approach for established pet industry players seeking digital marketplace capabilities. The 2025 strategy evaluates the acquisition offer while continuing marketplace growth across the US, UK, and UAE pet markets.
Pittsburgh ambient clinical AI (founded by cardiologist) at $5.3B valuation Jun 2025; $800M total ($300M a16z/Khosla Series E) deployed at UPMC 12K clinicians, Mayo Clinic, Johns Hopkins competing with Nuance DAX for physician documentation.
About
Abridge is a Pittsburgh, Pennsylvania-based healthcare AI clinical documentation platform — backed with approximately $800 million in total funding including a $300 million Series E in June 2025 led by Andreessen Horowitz and Khosla Ventures at a $5.3 billion valuation, following a $250 million Series D just four months prior at a $2.8 billion valuation — providing physicians, nurses, and care teams at 150+ health systems with AI that automatically converts patient-clinician conversations into structured clinical notes, saving physicians an average of 3 hours daily and generating high-quality documentation from UPMC (scaling to 12,000 clinicians enterprise-wide), Mayo Clinic, Johns Hopkins, and Emory Healthcare. Abridge's AI is trained on a proprietary dataset of over 1.5 million medical encounters, delivering specialty-specific documentation through deep Epic EHR integration. Founded in 2018 by cardiologist Dr. Shiv Rao.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.